This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/usa/532833-fda-pfizer-vaccine-covid-approval/
The article has changed 3 times. There is an RSS feed of changes available.
| Version 0 | Version 1 |
|---|---|
| Pfizer’s Covid-19 shot fully approved by US regulator for use in over-16s | Pfizer’s Covid-19 shot fully approved by US regulator for use in over-16s |
| (3 days later) | |
| The US drugs regulator has granted full approval for Pfizer/BioNTech’s Covid-19 vaccine for use in people over 16, although it will remain under emergency use authorization for those aged 12-15 and for booster shots. | The US drugs regulator has granted full approval for Pfizer/BioNTech’s Covid-19 vaccine for use in people over 16, although it will remain under emergency use authorization for those aged 12-15 and for booster shots. |
| On Monday, the US Food and Drug Administration (FDA) made Pfizer’s Covid-19 shot the first vaccine in America to be granted full approval for use in adults. The jab had been authorized for emergency use since mid-December 2020. | On Monday, the US Food and Drug Administration (FDA) made Pfizer’s Covid-19 shot the first vaccine in America to be granted full approval for use in adults. The jab had been authorized for emergency use since mid-December 2020. |
| The FDA stated that the vaccine will retain its emergency use authorization for use in adolescents aged 12-15, and for those requiring a third dose due to other health conditions. | The FDA stated that the vaccine will retain its emergency use authorization for use in adolescents aged 12-15, and for those requiring a third dose due to other health conditions. |
| According to the Centers for Disease Control and Prevention, around 92 million people in the US have been fully vaccinated by the Pfizer jab. The shot has also been widely used around the world. | According to the Centers for Disease Control and Prevention, around 92 million people in the US have been fully vaccinated by the Pfizer jab. The shot has also been widely used around the world. |
| It is believed that a small number of people in the US had been waiting for the vaccine to be fully approved before receiving their lifesaving shots, according to US Surgeon General Dr. Vivek Murthy, who spoke to CNN on Sunday. | It is believed that a small number of people in the US had been waiting for the vaccine to be fully approved before receiving their lifesaving shots, according to US Surgeon General Dr. Vivek Murthy, who spoke to CNN on Sunday. |
| Early studies suggested the vaccine was at least 90% effective in preventing symptomatic Covid-19, although the presence of variants, along with other factors, is likely to have reduced this figure. | Early studies suggested the vaccine was at least 90% effective in preventing symptomatic Covid-19, although the presence of variants, along with other factors, is likely to have reduced this figure. |
| US officials are preparing to make booster shots widely available in September, as studies suggest that vaccine efficacy – including that of Pfizer – wanes over time. | US officials are preparing to make booster shots widely available in September, as studies suggest that vaccine efficacy – including that of Pfizer – wanes over time. |
| It is likely that the Pfizer vaccine will be widely used once again for America’s follow-up jabs, with early data from Israel indicating a considerable increase in the presence of neutralizing antibodies after the third dose. | It is likely that the Pfizer vaccine will be widely used once again for America’s follow-up jabs, with early data from Israel indicating a considerable increase in the presence of neutralizing antibodies after the third dose. |
| If you like this story, share it with a friend! | If you like this story, share it with a friend! |
| Dear readers and commenters, | |
| We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system. | |
| Sorry for the inconvenience, and looking forward to your future comments, | |
| RT Team. |